Brief: Lundbeck, Otsuka Submit sNDA For FDA Review Of Brexpiprazole And Sertraline Combination
April 9 (Reuters) - H Lundbeck A/S HLUNb.CO :
* LUNDBECK AND OTSUKA SUBMIT SNDA FOR FDA REVIEW OF
BREXPIPRAZOLE
AND SERTRALINE COMBINATION AS POTENTIAL TREATMENT FOR PTSD
Source text for Eikon: ID:nWkr7MLGGd
Further company coverage: HLUNb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on H Lundbeck A/S
See all newsUBS upgrades Lundbeck to 'buy' on high epilepsy drug conviction
DB downgrades Lundbeck to 'sell' on Rexulti patent cliff risk
Europe Research Roundup: ASM International, Michelin, Nokian Renkaat
Europe Research Roundup: BAWAG Group, Enka Insaat, Partners Group Holding
Europe Research Roundup: BMW, Fugro, Mercedes-Benz